Patients with hematological malignancies who are prescribed quinolone prophylaxis postchemotherapy in a hospital with high gram-negative quinolone resistance are at a higher risk for febrile neutropenia
International Journal Of Infectious DiseasesPeer ReviewedEsther Ng +52010Journals
The content you want is available to Zendy users.
Already have an account? Sign inHaving issues? Contact support